Pseudohallucinations after zolpidem intake: A case report

Journal of Clinical Psychopharmacology

Volumn 27, Issue 6, 2007, Pages 728-730

  De Haas, Sanne ^a   Dingemanse, Jasper ^b   Hoever, Petra ^b   Cohen, Adam ^a   Van Gerven, Joop ^a  

^a CENTRE FOR HUMAN DRUG RESEARCH   (Netherlands)

^b ACTELION PHARMACEUTICALS LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ZOLPIDEM; HYPNOTIC SEDATIVE AGENT; PYRIDINE DERIVATIVE;

ADULT; ALERTNESS; BODY POSTURE; CASE REPORT; DIPLOPIA; DIZZINESS; DRUG BLOOD LEVEL; DRUG SAFETY; DYSPHASIA; HUMAN; LETTER; MALE; NAUSEA; PRIORITY JOURNAL; PSEUDOHALLUCINATION; PSYCHOMETRY; SIDE EFFECT; SOMNOLENCE; VISUAL ANALOG SCALE; VISUAL HALLUCINATION; BLOOD; CHEMICALLY INDUCED DISORDER; HALLUCINATION;

ADULT; HALLUCINATIONS; HUMANS; HYPNOTICS AND SEDATIVES; MALE; PYRIDINES;

EID: 39649112015     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31815a5806     Document Type: Letter

References (12)

1. Morlock RJ, Tan M, Mitchell DY. Patient characteristics and patterns of drug use for sleep complaints in the United States: analysis of National Ambulatory Medical Survey data, 1997-2002. Clin Ther. 2006;28(7):1044-1053.
2. Elko CJ, Burgess JL, Robertson WO. Zolpidem-associated hallucinations and serotonin reuptake inhibition: a possible interaction. J Toxicol Clin Toxicol. 1998;36(3):195-203.
3. Markowitz JS, Rames LJ, Reeves N, et al. Zolpidem and hallucinations. Ann Emerg Med. 1997;29(2):300-301.
4. Ansseau M, Pitchot W, Hansenne M, et al. Psychotic reactions to zolpidem. Lancet. 1992;339(8796):809.
5. Toner LC, Tsambiras BM, Catalano G, et al. Central nervous system side effects associated with zolpidem treatment. Clin Neuropharmacol. 2000;23(1):54-58.
6. Brisbare-Roch C, Dingemanse J, Koberstein R, et al. Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat Med. 2007;13(2):150-155.
7. Zuurman L, Roy C, Schoemaker RC, et al. Effect of intrapulmonary THC administration in humans. 2007. J Clin Psychopharmacol. In press.
8. Drover DR. Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone. Clin Pharmacokinet. 2004;43(4):227-238.
9. Dundee JW. Fantasies during sedation with intravenous midazolam or diazepam. Med Leg J. 1990;58(pt 1):29-34.
10. Litchfield NB. Complications of intravenous diazepam - adverse psychological reactions. (An assessment of 16,000 cases). Anesth Prog. 1980;28(6):175-183.
11. Tsai MJ, Huang YB, Wu PC. A novel clinical pattern of visual hallucination after zolpidem use. J Toxicol Clin Toxicol. 2003;41(6):869-872.
12. van Steveninck AL, Schoemaker HC, den Hartigh J, et al. Effects of intravenous temazepam. I. Saccadic eye movements and electroencephalogram after fast and slow infusion to pseudo steady state. Clin Pharmacol Ther. 1994;55(5):535-545.